Why is antibiotic stewardship important in LTC?

Why is antibiotic stewardship important in LTC?

• A. To maximize antibiotic use to prevent infections.
• B. To optimize antibiotic use, improve resident outcomes, reduce adverse events, and limit antibiotic resistance.
• C. To ensure every resident receives antibiotics.
• D. To eliminate antibiotic prescribing entirely.

Answer: (B)

Antibiotic stewardship in long-term care is about using antibiotics responsibly: diagnosing accurately, selecting the right drug, giving the proper dose, limiting the duration, and reassessing therapy to stop when it’s no longer needed. In LTC, residents often have many health conditions and exhibit symptoms that can be nonspecific, which can lead to unnecessary antibiotic use or delays in stopping them. By optimizing when antibiotics are started, choosing narrower-spectrum agents when appropriate, avoiding treatment for viral infections, and applying evidence-based treatment lengths, several benefits follow. Residents experience fewer adverse drug events and complications, such as C. difficile infections, and the risk of antibiotic resistance in the facility declines. It also helps reduce hospitalizations and drug interactions from polypharmacy. Ultimately, the goal is to ensure antibiotics provide real benefit for true infections while minimizing harm, rather than simply increasing or eliminating antibiotic use.

Antibiotic stewardship in long-term care is about using antibiotics responsibly: diagnosing accurately, selecting the right drug, giving the proper dose, limiting the duration, and reassessing therapy to stop when it’s no longer needed. In LTC, residents often have many health conditions and exhibit symptoms that can be nonspecific, which can lead to unnecessary antibiotic use or delays in stopping them. By optimizing when antibiotics are started, choosing narrower-spectrum agents when appropriate, avoiding treatment for viral infections, and applying evidence-based treatment lengths, several benefits follow. Residents experience fewer adverse drug events and complications, such as C. difficile infections, and the risk of antibiotic resistance in the facility declines. It also helps reduce hospitalizations and drug interactions from polypharmacy. Ultimately, the goal is to ensure antibiotics provide real benefit for true infections while minimizing harm, rather than simply increasing or eliminating antibiotic use.